CLDI Calidi Biotherapeutics, Inc.
$1.24▼ -5.34%
Healthcare
Other
After hours
$1.22▼ -1.61%
Sep 11, 5:37 PM ET
Volume 70.0K
Avg Volume (10D) 44.6K
Key Metrics & Fundamentals
Market Cap
$3.20M
P/E Ratio
–
Div Yield
–%
52W Range
1.22 - 27.84
% vs 50 MA
-24.82%
% vs 200 MA
-84.42%
RSI-14
34.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
2.19
Free Cash Flow
-$4.39M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.68M
COGS
–
Operating Exp
$4.15M
Operating Income
-$4.15M
EBIT
-$4.15M
Pretax Income
-$4.16M
Net Income
-$4.16M
EPS (Diluted)
-2.94
Price & Volume History
Loading chart…
Recent News
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 8, 2026 12:00 PM
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 13, 2026 8:30 PM
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
GlobeNewswire · Jul 27, 2026 12:00 PM
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
GlobeNewswire · Jul 21, 2026 12:00 PM
Calidi Biotherapeutics to Effect 1-for-16 Reverse Stock Split
MT Newswires · Jul 20, 2026 8:58 PM
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
GlobeNewswire · Jul 20, 2026 8:30 PM
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
GlobeNewswire · Jul 8, 2026 8:05 PM
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
GlobeNewswire · Jun 24, 2026 12:00 PM
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
GlobeNewswire · Jun 23, 2026 12:00 PM
Calidi Biotherapeutics Receives Positive Feedback From FDA for CLD-401 Pre-IND Application
MT Newswires · Jun 16, 2026 12:52 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CLDI's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.